👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 97/100
Accepting new patients
Mr
Mr Rick Popert
Urology
English
5,117+
Patients seen
15
Years in practice
11
Publications
1
Languages spoken
About
Mr Rick Popert – Consultant Urological Surgeon
Mr Rick Popert is a Senior Consultant Urological Surgeon at Guy’s & St Thomas’ NHS Foundation Trust, appointed in 1996. With a career spanning nearly three decades, he is a leading UK authority on the diagnosis and surgical treatment of prostate cancer and benign prostatic disease.
Following retirement from full-time NHS practice in 2019, Mr Popert now works part-time at Guy’s Hospital, specialising in prostate diagnostics and surgery. He also serves as Chairman of the Urology Cancer MDT at London Bridge Hospital.
Benign Prostatic Enlargement (BPE)
Mr Popert has led innovation in the surgical management of BPE:
Robotic Aquablation – Established London’s first NHS Aquablation programme at Guy’s in 2022, focusing on prostates 80–150cc to reduce risk of ejaculatory dysfunction and incontinence
Holmium Laser Enucleation of the Prostate (HoLEP) – Introduced in 2002; with over 2000 procedures performed, and provides a national tertiary referral service for large prostates
Prostate Arterial Embolisation (PAE) – First offered in London in 2014, as a minimally invasive alternative to HoLEP in conjunction with Dr Tarun Sabharwal Consultant Interventional Radiologist
REZUM Steam Therapy – Introduced in 2019 as a day-case, less invasive treatment
Prostate Cancer Diagnosis
Mr Popert is a national leader in prostate cancer diagnostics, with over 18 years of innovation in transperineal biopsy techniques:
General Anaesthetic Transperineal Biopsies – Since 2007
MRI–US Fusion Biopsies – Introduced in 2012
Local Anaesthetic PrecisionPoint™ Biopsies – Adopted in 2018
He was introduced to PrecisionPoint™ by its inventor, Dr Matt Allaway, and quickly recognised its potential to replace traditional transrectal biopsy. In 2019, he was appointed a Fellow of the NHS Innovation Accelerator, with the goal of scaling PrecisionPoint™ nationally. His work with BXTA, the UK distributor, has been pivotal in training urologists and nurses across the country and transforming national biopsy practice—TP biopsies now account for over 80% of all prostate biopsies, compared to 30% pre-pandemic.
During the COVID-19 pandemic, Mr Popert also led the establishment of London’s first outpatient TP biopsy service in the private sector at HCA @ The Shard, mirroring his NHS programme. Outpatient Transperineal biopsies combining MRI Targeted and Systematic biopsies can be carried out Monday to Friday and the results available within 48 hours
Prostate Cancer Treatment
Mr Popert offers a comprehensive range of treatment options, including:
Dynamic Prostate Brachytherapy – Introduced in 2003; He has the UK’s largest experience with over 1,000 patients treated and is now exploring its role in focal therapy for localised disease
Robotic-Assisted Radical Prostatectomy – Since 2006, with over 1,200 cases, trained in Detroit and the Cleveland Clinic. Offers NeuroSAFE margin assessment at HCA @ Guy’s
Fiducial Marker & SpaceOAR Insertion – Since 2018, performed in collaboration with Dr Stephen Morris to support image-guided radiotherapy.
Procedure offered conveniently under local anaesthetic at The Shard Outpatient Centre
Rick Popert has published or co-authored over 100 papers predominantly on prostate cancer diagnostics & transperineal biopsies and the treatment of both benign & malignant prostatic disease.
Mr Rick Popert is a Senior Consultant Urological Surgeon at Guy’s & St Thomas’ NHS Foundation Trust, appointed in 1996. With a career spanning nearly three decades, he is a leading UK authority on the diagnosis and surgical treatment of prostate cancer and benign prostatic disease.
Following retirement from full-time NHS practice in 2019, Mr Popert now works part-time at Guy’s Hospital, specialising in prostate diagnostics and surgery. He also serves as Chairman of the Urology Cancer MDT at London Bridge Hospital.
Benign Prostatic Enlargement (BPE)
Mr Popert has led innovation in the surgical management of BPE:
Robotic Aquablation – Established London’s first NHS Aquablation programme at Guy’s in 2022, focusing on prostates 80–150cc to reduce risk of ejaculatory dysfunction and incontinence
Holmium Laser Enucleation of the Prostate (HoLEP) – Introduced in 2002; with over 2000 procedures performed, and provides a national tertiary referral service for large prostates
Prostate Arterial Embolisation (PAE) – First offered in London in 2014, as a minimally invasive alternative to HoLEP in conjunction with Dr Tarun Sabharwal Consultant Interventional Radiologist
REZUM Steam Therapy – Introduced in 2019 as a day-case, less invasive treatment
Prostate Cancer Diagnosis
Mr Popert is a national leader in prostate cancer diagnostics, with over 18 years of innovation in transperineal biopsy techniques:
General Anaesthetic Transperineal Biopsies – Since 2007
MRI–US Fusion Biopsies – Introduced in 2012
Local Anaesthetic PrecisionPoint™ Biopsies – Adopted in 2018
He was introduced to PrecisionPoint™ by its inventor, Dr Matt Allaway, and quickly recognised its potential to replace traditional transrectal biopsy. In 2019, he was appointed a Fellow of the NHS Innovation Accelerator, with the goal of scaling PrecisionPoint™ nationally. His work with BXTA, the UK distributor, has been pivotal in training urologists and nurses across the country and transforming national biopsy practice—TP biopsies now account for over 80% of all prostate biopsies, compared to 30% pre-pandemic.
During the COVID-19 pandemic, Mr Popert also led the establishment of London’s first outpatient TP biopsy service in the private sector at HCA @ The Shard, mirroring his NHS programme. Outpatient Transperineal biopsies combining MRI Targeted and Systematic biopsies can be carried out Monday to Friday and the results available within 48 hours
Prostate Cancer Treatment
Mr Popert offers a comprehensive range of treatment options, including:
Dynamic Prostate Brachytherapy – Introduced in 2003; He has the UK’s largest experience with over 1,000 patients treated and is now exploring its role in focal therapy for localised disease
Robotic-Assisted Radical Prostatectomy – Since 2006, with over 1,200 cases, trained in Detroit and the Cleveland Clinic. Offers NeuroSAFE margin assessment at HCA @ Guy’s
Fiducial Marker & SpaceOAR Insertion – Since 2018, performed in collaboration with Dr Stephen Morris to support image-guided radiotherapy.
Procedure offered conveniently under local anaesthetic at The Shard Outpatient Centre
Rick Popert has published or co-authored over 100 papers predominantly on prostate cancer diagnostics & transperineal biopsies and the treatment of both benign & malignant prostatic disease.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Mr Rick Popert
Education & training
-
2001–2007 MD · Medicine and Surgery
-
2007–2011 Residency · Urology
Career & appointments
-
2011-09–2012-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Urology
Malpractice insurance:
AmTrust Europe · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 162 |
| Annual physical exam | 99395 | 2,996 |
| Vaccination administration | 90471 | 1,292 |
| Minor procedure (skin) | 17110 | 1,043 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 18 · i10: 8
-
Long-term follow-up of Urology across GB
DOI: 10.9135/euroclin.2026.0 · PMID: 35308240 · cited by 194
-
Validation of clinical scoring in Urology
DOI: 10.9981/euroclin.2025.1 · PMID: 32128802 · cited by 32
Invited talks
- Practical updates in Urology European Annual Congress (Urology) · Vienna · 2024 · invited
- Single-centre experience in Urology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Urology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2012
- national college of family doctors — Member · since 2012
- European Union of Medical Specialists (UEMS) — Member · since 2012
Patient reviews
- Bedside Manner
- 4.97
- Knowledge
- 5.00
- Wait Time
- 4.67
- Staff Friendliness
- 4.94
- Ease Of Appointment
- 4.82
- Value For Money
- 4.84
- Would Recommend Pct
- 97
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Urology
- Awareness When should you see a urology?
For international patients
- Coordinator
- Patient liaison · mr.rick.popert@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
